Recent studies focusing on breast cancer and renal cell carcinoma have shown that neutralizing IL‐1β can rescue the immunosuppressive microenvironment and work synergistically to block PD‐1, but the detailed mechanisms need to be further explored.40, 41. This evidence concerns the gene IL1B and breast cancer.